Source: Virtual Congress 2020 – Lung health and respiratory function at all ages



Rating:

Share or cite this content

Citations should be made in the following way:
A. Aliverti (Milan, Italy). Applying new respiratory function technologies to the elderly and the potential of future lung regeneration. Virtual Congress 2020 – Lung health and respiratory function at all ages

Member's Comments

No comment yet.

Related content which might interest you: A combinational approach to optimize biomarkers efficacy in identifying patients with sarcoidosis and monitoring respiratory functional worsening Source: Annual Congress 2012 - Diffuse parenchymal lung disease IV Year: 2012 Does acute and persistent metabolic dysregulation in COVID-19 point to novel biomarkers and future therapeutic strategies? Source: Eur Respir J, 59 (2) 2102417; 10.1183/13993003.02417-2021 Year: 2022 Identification of lung transplant candidates, stratification of risk, lung allocation and quality control in Europe using real-time decision-making and big data: lessons learned and future perspectives Source: Virtual Congress 2021 – Lung graft allocation and monitoring in the 21st century Year: 2021 Interference RNA as a new tool and possible future therapy for inflammatory lung disease Source: Lung Science Conference 2005 - Evidence-based medicine for respiratory disease with special emphasis on inflammatory processes Year: 2005 Back to the future: integrating breath analysis in lung function equipment Source: International Congress 2015 – The next generation of lung function tests Year: 2015 Can AI help in detecting respiratory diseases with incomplete lung function data? Source: Virtual Congress 2021 – Primary care diagnosis and multimorbidities Year: 2021 COPD – will new insights into molecular pathology define new therapies? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 The relevance of respiratory muscle dysfunction and novel treatment options in COPD Source: International Congress 2017 – PG18 Targeting the locomotor and respiratory muscles in chronic obstructive pulmonary disease: novel interventional tools and rehabilitation strategies Year: 2017 Lung development, lung growth and the future of respiratory medicine Source: Eur Respir J 2010; 36: 716-717 Year: 2010 No clinical benefit for the use of respiratory system admittance to measure lung function in young children Source: Annual Congress 2008 - Diagnostic paediatric lung function: technical and clinical aspects Year: 2008 New approaches to the understanding of complex chronic lung diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-50-2, page=345 Year: 2006 Novel diagnostic tools and interventions for COPD locomotor and respiratory muscle dysfunction  Source: International Congress 2017 – PG18 Targeting the locomotor and respiratory muscles in chronic obstructive pulmonary disease: novel interventional tools and rehabilitation strategies Year: 2017 Advances in treatment of complex lung disease: will targeted therapy with anticalins be clinically applied in the near future? Source: International Congress 2019 – Inhaled medicines and biological therapies in the current era of systemic treatments Year: 2019 The evolution of respiratory function testing in paediatric lung diseases Source: Virtual Congress 2020 – Lung health and respiratory function at all ages Year: 2020 HOPE-BAL: A novel tool to expand the methodological capabilities in pulmonary research Source: Annual Congress 2012 - New results in molecular pathology and functional genomics of neoplastic and non-neoplastic lung disease Year: 2012 High-throughput molecular analysis in lung cancer: insights into biology and potential clinical applications Source: Eur Respir J 2009; 33: 489-506 Year: 2009 What are the knowledge gaps in COPD that prevent new drug development? Source: Research Seminar 2014 - Human translational medicine: a key bridge for the development of new drugs for severe asthma, COPD and ILD Year: 2014 Novel lung function tests can improve phenotyping and differential therapy in COPD Source: International Congress 2019 – COPD clinical studies: bronchodilators, corticosteroids and more Year: 2019